Wolfe Research Downgrades Ionis Pharmaceuticals (IONS) to Peerperform

July 16, 2026 2:22 AM

Wolfe Research analyst Andy Chen downgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Outperform to Peerperform.The analyst comments: “Downgrade IONS to Peer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found